Daptomycin-Induced Pulmonary Toxicity: A Case Series.
Publication/Presentation Date
5-1-2023
Abstract
Daptomycin is a bactericidal antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Eosinophilic pneumonia is an uncommon but significant adverse effect of daptomycin. We present two patients treated with daptomycin who subsequently developed eosinophilic pneumonia (EP).
Volume
15
Issue
5
First Page
39613
Last Page
39613
ISSN
2168-8184
Published In/Presented At
Patel, Y. I., Natarajan, S., Ramakrishna, S., & Ochieng, P. (2023). Daptomycin-Induced Pulmonary Toxicity: A Case Series. Cureus, 15(5), e39613. https://doi.org/10.7759/cureus.39613
Disciplines
Medicine and Health Sciences
PubMedID
37384075
Department(s)
Department of Medicine
Document Type
Article
COinS